Saini, R.; Fatima, S.; Aggarwal, S.M.
(Blackwell Publishing Ltd, 2020-09-01)
The EGFR is a clinically important therapeutic drug target in lung cancer. The first-generation tyrosine kinase inhibitors used in clinics are effective against L858R-mutated EGFR. However, relapse of the disease due to ...